178 related articles for article (PubMed ID: 2674877)
1. [Dermatan sulfate and the prevention of experimental venous thrombosis].
Desnoyers P; Bara L; Samama M
Pathol Biol (Paris); 1989 Jun; 37(6):759-67. PubMed ID: 2674877
[TBL] [Abstract][Full Text] [Related]
2. The haemorrhagic and antithrombotic effects of dermatan sulphate.
Fernandez F; Van Ryn J; Ofosu FA; Hirsh J; Buchanan MR
Br J Haematol; 1986 Oct; 64(2):309-17. PubMed ID: 3778825
[TBL] [Abstract][Full Text] [Related]
3. Pharmacologic properties of a low molecular weight dermatan sulfate: comparison with unfractionated dermatan sulfate.
Dol F; Petitou M; Lormeau JC; Choay J; Caranobe C; Sie P; Saivin S; Houin G; Boneu B
J Lab Clin Med; 1990 Jan; 115(1):43-51. PubMed ID: 2299256
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological actions of sulodexide.
Ofosu FA
Semin Thromb Hemost; 1998; 24(2):127-38. PubMed ID: 9579633
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms for the anticoagulant effect of heparin and related polysaccharides.
Ofosu FA
Nouv Rev Fr Hematol (1978); 1988; 30(3):155-60. PubMed ID: 2971155
[TBL] [Abstract][Full Text] [Related]
6. Heparin cofactor II and other endogenous factors in the mediation of the antithrombotic and anticoagulant effects of heparin and dermatan sulfate.
Ofosu FA; Fernandez F; Gauthier D; Buchanan MR
Semin Thromb Hemost; 1985 Apr; 11(2):133-7. PubMed ID: 3898370
[No Abstract] [Full Text] [Related]
7. Experimental studies on the relative efficacy of dermatan sulphate and heparin as antithrombotic agents.
Merton RE; Thomas DP
Thromb Haemost; 1987 Oct; 58(3):839-42. PubMed ID: 3433248
[TBL] [Abstract][Full Text] [Related]
8. Effects on platelets and on the clotting system of four glycosaminoglycans extracted from hog mucosa and one extracted from aortic intima of the calf.
Cella G; Scattolo N; Luzzatto G; Stevanato F; Vio C; Girolami A
J Med; 1986; 17(5-6):331-46. PubMed ID: 2953835
[TBL] [Abstract][Full Text] [Related]
9. Rationale behind the development of low molecular weight heparin derivatives.
Hirsh J; Ofosu F; Buchanan M
Semin Thromb Hemost; 1985 Jan; 11(1):13-6. PubMed ID: 2579436
[TBL] [Abstract][Full Text] [Related]
10. Antithrombotic activity of dermatan sulphates, heparins and their combination in an animal model of arterial thrombosis.
Iacoviello L; D'Adamo MC; Pawlak K; Polishchuck R; Wollny T; Buczko W; Donati MB
Thromb Haemost; 1996 Dec; 76(6):1102-7. PubMed ID: 8972038
[TBL] [Abstract][Full Text] [Related]
11. Effect of oversulphated chondroitin and dermatan sulphate upon thrombin and factor Xa inactivation by antithrombin III or heparin cofactor II.
Scully MF; Ellis V; Seno N; Kakkar VV
Biochem J; 1988 Sep; 254(2):547-51. PubMed ID: 2902851
[TBL] [Abstract][Full Text] [Related]
12. An algal sulfated galactan has an unusual dual effect on venous thrombosis due to activation of factor XII and inhibition of the coagulation proteases.
Melo FR; Mourão PA
Thromb Haemost; 2008 Mar; 99(3):531-8. PubMed ID: 18327401
[TBL] [Abstract][Full Text] [Related]
13. Standard heparin enhances the antithrombotic activity of dermatan sulfate in the rabbit but CY 216 does not.
Cadroy Y; Dol F; Caranobe C; Petitou M; Lormeau JC; Sié P; Choay J; Boneu B
Thromb Haemost; 1988 Apr; 59(2):295-8. PubMed ID: 2838927
[TBL] [Abstract][Full Text] [Related]
14. Unbalanced effects of dermatan sulfates with different sulfation patterns on coagulation, thrombosis and bleeding.
Vicente CP; Zancan P; Peixoto LL; Alves-Sá R; Araújo FS; Mourão PA; Pavão MS
Thromb Haemost; 2001 Nov; 86(5):1215-20. PubMed ID: 11816710
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological properties of dermatan sulfate, of a low molecular weight dermatan sulfate and of two oversulfated derivatives.
Dol F; Petitou M; Choay J; Sie P; Houin G; Boneu B
Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(6):851-7. PubMed ID: 2483702
[TBL] [Abstract][Full Text] [Related]
16. Activation of heparin cofactor II by heparin and dermatan sulfate.
Tollefsen DM
Nouv Rev Fr Hematol (1978); 1984; 26(4):233-7. PubMed ID: 6548014
[TBL] [Abstract][Full Text] [Related]
17. The venous antithrombotic profile of naroparcil in the rabbit.
Millet J; Theveniaux J; Brown NL
Thromb Haemost; 1994 Dec; 72(6):874-9. PubMed ID: 7740457
[TBL] [Abstract][Full Text] [Related]
18. Fibrin moderates the catalytic action of heparin but not that of dermatan sulfate on thrombin inhibition in human plasma.
Okwusidi JI; Anvari N; Kulczycky M; Blajchman MA; Buchanan MR; Ofosu FA
J Lab Clin Med; 1991 May; 117(5):359-64. PubMed ID: 2019790
[TBL] [Abstract][Full Text] [Related]
19. A survey of the clinical experience with dermatan sulfate.
Gianese F; Lucchelli PE
Semin Thromb Hemost; 1991; 17 Suppl 2():199-204. PubMed ID: 1948090
[No Abstract] [Full Text] [Related]
20. Effects of heparin, dermatan sulfate and of their association on the inhibition of venous thrombosis growth in the rabbit.
Carrie D; Caranobe C; Gabaig AM; Larroche M; Boneu B
Thromb Haemost; 1992 Dec; 68(6):637-41. PubMed ID: 1287877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]